Temasek Holdings Private Ltd Buys Shares of 7,462 Tempus AI, Inc. $TEM

Key Points

• Temasek Holdings acquired 7,462 shares of Tempus AI, Inc. valued at approximately $360,000 in the first quarter of 2023.
• Insider sales included CFO James William Rogers selling 7,528 shares and COO Ryan Fukushima selling 17,460 shares, with both trades occurring at an average price of $74.65.
• Several analysts have given Tempus AI a consensus rating of "Moderate Buy" with an average price target of $69.50, reflecting a positive outlook for the company's growth.

Temasek Holdings Private Ltd bought a new stake in Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the first quarter, according to its most recent disclosure with the SEC. The institutional investor bought 7,462 shares of the company's stock, valued at approximately $360,000.

Several other large investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its holdings in shares of Tempus AI by 6,247.5% during the 1st quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company's stock valued at $289,204,000 after acquiring an additional 5,900,668 shares in the last quarter. ARK Investment Management LLC lifted its stake in shares of Tempus AI by 35.9% in the first quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company's stock valued at $361,867,000 after buying an additional 1,981,755 shares in the last quarter. Nikko Asset Management Americas Inc. boosted its position in shares of Tempus AI by 31.5% during the first quarter. Nikko Asset Management Americas Inc. now owns 4,260,553 shares of the company's stock valued at $205,401,000 after buying an additional 1,021,460 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. grew its stake in shares of Tempus AI by 31.4% in the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company's stock worth $205,284,000 after acquiring an additional 1,016,384 shares in the last quarter. Finally, CloudAlpha Capital Management Limited Hong Kong bought a new stake in shares of Tempus AI during the 1st quarter worth $34,119,000. Institutional investors own 24.22% of the company's stock.

Tempus AI Trading Up 1.0%

Shares of TEM stock traded up $0.79 during midday trading on Tuesday, reaching $81.01. 6,502,834 shares of the company traded hands, compared to its average volume of 10,927,365. The company has a debt-to-equity ratio of 2.58, a current ratio of 1.54 and a quick ratio of 1.43. Tempus AI, Inc. has a 1-year low of $31.36 and a 1-year high of $91.45. The firm's 50 day simple moving average is $66.15 and its two-hundred day simple moving average is $59.16.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its quarterly earnings results on Friday, August 8th. The company reported ($0.22) EPS for the quarter, beating the consensus estimate of ($0.23) by $0.01. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. The firm had revenue of $314.64 million for the quarter, compared to analyst estimates of $296.84 million. During the same quarter last year, the firm posted ($6.86) earnings per share. Tempus AI's revenue for the quarter was up 89.5% compared to the same quarter last year. Tempus AI has set its FY 2025 guidance at EPS. Equities research analysts anticipate that Tempus AI, Inc. will post -6.15 EPS for the current year.

Insider Buying and Selling

In related news, CFO James William Rogers sold 7,528 shares of the company's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total value of $561,965.20. Following the completion of the sale, the chief financial officer owned 138,473 shares in the company, valued at approximately $10,337,009.45. This represents a 5.16% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Ryan Fukushima sold 17,460 shares of the firm's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total value of $1,303,389.00. Following the sale, the chief operating officer owned 839,180 shares of the company's stock, valued at $62,644,787. The trade was a 2.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 1,108,951 shares of company stock valued at $77,660,938. Company insiders own 26.27% of the company's stock.

Analysts Set New Price Targets

TEM has been the subject of a number of research reports. Guggenheim upped their price objective on shares of Tempus AI from $65.00 to $75.00 and gave the company a "buy" rating in a research note on Monday, June 30th. HC Wainwright initiated coverage on Tempus AI in a research note on Tuesday, September 2nd. They set a "buy" rating and a $90.00 price target for the company. Bank of America upped their target price on shares of Tempus AI from $68.00 to $70.00 and gave the stock a "neutral" rating in a research note on Wednesday, June 25th. Needham & Company LLC restated a "buy" rating and issued a $70.00 target price on shares of Tempus AI in a research note on Friday, August 8th. Finally, Morgan Stanley upped their price objective on shares of Tempus AI from $65.00 to $68.00 and gave the stock an "overweight" rating in a research report on Tuesday, August 12th. Seven analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $69.50.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.